Mitigating Doxorubicin-Induced Cardiotoxicity through Quercetin Intervention: An Experimental Study in Rats
Doxorubicin (DOX) is an effective anticancer drug, but its use is limited by dose-dependent heart toxicity. Quercetin is a natural antioxidant frequently studied for its beneficial properties. Moreover, a wide range of dietary supplements are available for human use. This in vivo study aimed to expl...
Saved in:
Main Authors: | Patricia Lorena Dulf (Author), Camelia Alexandra Coadă (Author), Adrian Florea (Author), Remus Moldovan (Author), Ioana Baldea (Author), Daniel Vasile Dulf (Author), Dan Blendea (Author), Adriana Gabriela Filip (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
by: Hamidreza Dorostkar, et al.
Published: (2023) -
Doxorubicin Cardiotoxicity: An Update Regarding the Mechanism of Toxicity and Mitigation Strategies of Bee Propolis
by: Hodhaifa Abdul Mohsin, et al.
Published: (2023) -
Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
by: Lan Li, et al.
Published: (2017) -
Albumin-Based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin
by: Zehua Shao, et al.
Published: (2022) -
Goji-Berry-Mediated Green Synthesis of Gold Nanoparticles and Their Promising Effect on Reducing Oxidative Stress and Inflammation in Experimental Hyperglycemia
by: Luminita David, et al.
Published: (2023)